Introductory Remarks

  • Thomas Brandt
  • Marianne Dieterich
  • Michael Strupp


Signs and symptoms of clinical vertigo syndromes are described according to the major perceptual and motor functions of the vestibular system. History taking is particularly important. It includes types, duration, and triggers of vertigo and accompanying symptoms such as audiological and visual impairments and a combination of dizziness and vertigo with headache. A table provides information about the frequency of various forms of vertigo.

The neuro-ophthalmological and neuro-otological examinations are described with which ocular motor and vestibular functions are tested. They are richly illustrated by 15 figures. In addition, laboratory and imaging examinations, such as video-oculography, vestibular-evoked myogenic potentials, audiometry, posturography, and gait analysis as well as advanced CT and MRI techniques relevant for the management of patients, are explained.

General principles of therapy are discussed separately for medical treatment, physical therapy, surgery, and psychological/psychiatric and behavioral treatment.


Smooth Pursuit Vestibular Schwannoma Subjective Visual Vertical Vestibular Neuritis Vestibular Migraine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Bartl K, Lehnen N, Kohlbecher S, Schneider E. Head impulse testing using video-oculography. Ann N Y Acad Sci. 2009;1164:331–3.PubMedCrossRefGoogle Scholar
  2. Bisdorff A, von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19:1–13.PubMedGoogle Scholar
  3. Brandt T, Daroff RB. Physical therapy for benign paroxysmal positional vertigo. Arch Otolaryngol. 1980;106:484–5.PubMedCrossRefGoogle Scholar
  4. Brandt T, Dieterich M. Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet. 1994;343:798–9.PubMedCrossRefGoogle Scholar
  5. Brandt T, Strupp M, Novozhilov S, Krafczyk S. Artificial neural network posturography detects the transition of vestibular neuritis to phobic postural vertigo. J Neurol. 2012;259:182–4.PubMedCrossRefGoogle Scholar
  6. Cnyrim CD, Newman-Toker D, Karch C, Brandt T, Strupp M. Bedside differentiation of vestibular neuritis from central “vestibular pseudoneuritis”. J Neurol Neurosurg Psychiatry. 2008;79:458–60.PubMedCrossRefGoogle Scholar
  7. Davis A, Moorjani P. The epidemiology of hearing and balance disorders. In: Luxon LM, Furman JM, Martini A, Stephens D, editors. Textbook of audiological medicine. London: Dunitz M; 2003. p. 89–99.Google Scholar
  8. Glasauer S, Kalla R, Buttner U, Strupp M, Brandt T. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry. 2005;76:451–3.PubMedCrossRefGoogle Scholar
  9. Halmagyi GM, Curthoys IS. A clinical sign of canal paresis. Arch Neurol. 1988;45:737–9.PubMedCrossRefGoogle Scholar
  10. Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2011;2, CD005397.PubMedGoogle Scholar
  11. Hufner K, Barresi D, Glaser M, Linn J, Adrion C, Mansmann U, et al. Vestibular paroxysmia: diagnostic features and medical treatment. Neurology. 2008;71:1006–14.PubMedCrossRefGoogle Scholar
  12. Huppert D, Strupp M, Muckter H, Brandt T. Which medication do I need to manage dizzy patients? Acta Otolaryngol. 2011;131:228–41.PubMedCrossRefGoogle Scholar
  13. Kalla R, Glasauer S, Schautzer F, Lehnen N, Büttner U, Strupp M, et al. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology. 2004;62:1228–9.PubMedCrossRefGoogle Scholar
  14. Krafczyk S, Tietze S, Swoboda W, Valkovic P, Brandt T. Artificial neural network: a new diagnostic posturographic tool for disorders of stance. Clin Neurophysiol. 2006;117:1692–8.PubMedCrossRefGoogle Scholar
  15. Minor LB, Solomon D, Zinreich JS, Zee DS. Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg. 1998;124:149–258.CrossRefGoogle Scholar
  16. Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol. 2007;20:40–6.PubMedCrossRefGoogle Scholar
  17. Newman-Toker DE, Kattah JC, Alvernia JE, Wang DZ. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology. 2008;70:2378–85.PubMedCrossRefGoogle Scholar
  18. Rosengren SM, Welgampola MS, Colebatch JG. Vestibular evoked myogenic potentials: past, present and future. Clin Neurophysiol. 2010;121:636–51.PubMedCrossRefGoogle Scholar
  19. Royl G, Ploner CJ, Mockel M, Leithner C. Neurological chief complaints in an emergency room. Nervenarzt. 2010;81:1226–30.PubMedCrossRefGoogle Scholar
  20. Schniepp R, Wuehr M, Neuhaeusser M, Benecke AK, Adrion C, Brandt T, et al. 4-Aminopyridine and cerebellar gait: a retrospective case series. J Neurol. 2012a;259:2491–3.PubMedCrossRefGoogle Scholar
  21. Schniepp R, Wuehr M, Neuhaeusser M, Kamenova M, Dimitriadis K, Klopstock T, et al. Locomotion speed determines gait variability in cerebellar ataxia and vestibular failure. Mov Disord. 2012b;27:125–31.PubMedCrossRefGoogle Scholar
  22. Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Büttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology. 2003;61:165–70.PubMedCrossRefGoogle Scholar
  23. Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351:354–61.PubMedCrossRefGoogle Scholar
  24. Strupp M, Hupert D, Frenzel C, Wagner J, Zingler V, Mansmann U, et al. Long-term prophylactic treatment of attacks of vertigo in Meniere’s disease – comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008;128:520–4.PubMedCrossRefGoogle Scholar
  25. Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011a;77:269–75.PubMedCrossRefGoogle Scholar
  26. Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol. 2011b;258:1207–22.PubMedCrossRefGoogle Scholar
  27. Zingler VC, Weintz E, Jahn K, Bötzel K, Wagner J, Huppert D, et al. Saccular function less affected than canal function in bilateral vestibulopathy. J Neurol. 2008;255:1332–6.PubMedCrossRefGoogle Scholar
  28. Zwergal A, Rettinger N, Frenzel C, Frisen L, Brandt T, Strupp M. A bucket of static vestibular function. Neurology. 2009;72:1689–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Thomas Brandt
    • 1
  • Marianne Dieterich
    • 2
  • Michael Strupp
    • 2
  1. 1.Clinical Neurosciences and Center for Vertigo & Balance DisordersUniversity of MunichMunichGermany
  2. 2.Department of Neurology and Center for Vertigo & Balance DisordersUniversity of MunichMunichGermany

Personalised recommendations